Oats: The Heart Health Champion Whole grains are rich in fiber, antioxidants, and essential vitamins and minerals that ...

Topline data were announced from two phase 3 trials evaluating orforglipron, an oral GLP-1 receptor agonist, in patients with type 2 diabetes.

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by ...

Sanofi's Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program If approved, Tzield would be the first disease-mo ...

Last year’s initial net farm income forecast showed the two largest consecutive declines in net farm income history, the picture seems to be improving in 2025. According to USDA’s Economic Research ...

Eli Lilly finds itself navigating turbulent market conditions following unexpected political developments from the White House. Former President Donald Trump's recent announcement regarding ...

The use of GLP-1RAs may improve RA disease activity and cardiovascular risk profiles among patients with overweight or obesity.